-
Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
Biochemistry. 1996 Apr 23;35(16):5158-65
PMID: 8611499
-
NMR study of the peptide present in the principal neutralizing determinant (PND) of HIV-1 envelope glycoprotein gp120.
J Biochem Biophys Methods. 1997 Mar 27;34(2):83-98
PMID: 9178085
-
A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.
Science. 1998 Jun 19;280(5371):1949-53
PMID: 9632396
-
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.
Structure. 1999 Feb 15;7(2):131-42
PMID: 10368281
-
Preparation and properties of Nalpha-9-fluorenylmethyloxycarbonylamino acids bearing tert.-butyl side chain protection.
Int J Pept Protein Res. 1980 Jan;15(1):59-66
PMID: 7358458
-
Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
Biochemistry. 1997 Jul 15;36(28):8619-27
PMID: 9214308
-
Conformational features of a synthetic cyclic peptide corresponding to the complete V3 loop of the RF HIV-1 strain in water and water/trifluoroethanol solutions.
Eur J Biochem. 1996 Feb 15;236(1):100-8
PMID: 8617252
-
Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120.
Proteins. 1992 Dec;14(4):499-508
PMID: 1438187
-
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.
Cell. 1996 Jun 28;85(7):1135-48
PMID: 8674119
-
Unusually stable helix formation in short alanine-based peptides.
Proc Natl Acad Sci U S A. 1989 Jul;86(14):5286-90
PMID: 2748584
-
Structural comparison of a 15 residue peptide from the V3 loop of HIV-1IIIb and an O-glycosylated analogue.
FEBS Lett. 1996 Sep 16;393(2-3):280-6
PMID: 8814305
-
A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide.
Nat Struct Biol. 1999 Apr;6(4):331-5
PMID: 10201400
-
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
Nature. 1996 Nov 14;384(6605):179-83
PMID: 8906795
-
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.
Proc Natl Acad Sci U S A. 1988 May;85(9):3198-202
PMID: 2452447
-
Solution structure of the V3 loop of a Thailand HIV isolate.
J Biomol Struct Dyn. 1993 Oct;11(2):345-66
PMID: 8286061
-
Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.
Nat Struct Biol. 1999 Feb;6(2):141-5
PMID: 10048925
-
Prediction of the secondary structure of HIV-1 gp120.
Proteins. 1996 May;25(1):1-11
PMID: 8727315
-
Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.
J Virol. 1998 Jan;72(1):279-85
PMID: 9420225
-
Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations.
FEBS Lett. 1988 Mar 14;229(2):317-24
PMID: 3345845
-
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.
Science. 1990 Aug 24;249(4971):932-5
PMID: 2392685
-
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
Annu Rev Immunol. 1999;17:657-700
PMID: 10358771
-
V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11518-22
PMID: 7505441
-
Sampling and efficiency of metric matrix distance geometry: a novel partial metrization algorithm.
J Biomol NMR. 1992 Jan;2(1):33-56
PMID: 1422145
-
NMR structure of the principal neutralizing determinant of HIV-1 displayed in filamentous bacteriophage coat protein.
J Mol Biol. 1997 Mar 7;266(4):649-55
PMID: 9102458
-
Solution conformation of an immunogenic peptide derived from the principal neutralizing determinant of the HIV-2 envelope glycoprotein gp125.
Fold Des. 1996;1(2):157-65
PMID: 9079375
-
The antigenic structure of the HIV gp120 envelope glycoprotein.
Nature. 1998 Jun 18;393(6686):705-11
PMID: 9641684
-
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Nature. 1996 Nov 14;384(6605):184-7
PMID: 8906796
-
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.
Nature. 1998 Jun 18;393(6686):648-59
PMID: 9641677
-
Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates.
J Virol. 1998 May;72(5):4485-91
PMID: 9557746
-
NMR study and comparison of the antigenic properties of a peptide recognized by two HIV-1 neutralizing antibodies.
J Mol Recognit. 1997 Nov-Dec;10(6):256-61
PMID: 9770649
-
Raster3D: photorealistic molecular graphics.
Methods Enzymol. 1997;277:505-24
PMID: 18488322
-
Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6325-9
PMID: 8327513
-
Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
J Mol Biol. 1997 Feb 14;266(1):31-9
PMID: 9054968
-
Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain.
J Virol. 1991 Jan;65(1):190-4
PMID: 1985197
-
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.
Science. 1990 Dec 14;250(4987):1590-3
PMID: 1703322
-
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
J Virol. 1988 Jun;62(6):2107-14
PMID: 2452899
-
Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization.
Virology. 1993 Jan;192(1):197-206
PMID: 7685962
-
Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodies.
J Virol. 1999 Jan;73(1):746-50
PMID: 9847381
-
The principal neutralizing determinant of HIV-1 located in V3 of gp120 forms a 12-residue loop by internal hydrophobic interactions.
FEBS Lett. 1995 Jul 17;368(2):267-70
PMID: 7543061
-
Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design.
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8898-902
PMID: 3122208
-
Crystal structure of the principal neutralization site of HIV-1.
Science. 1994 Apr 1;264(5155):82-5
PMID: 7511253
-
The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection.
Nat Med. 1996 Nov;2(11):1244-7
PMID: 8898753
-
Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9434-8
PMID: 1409653
-
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
J Exp Med. 1997 Oct 20;186(8):1373-81
PMID: 9334377
-
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72
PMID: 2771954
-
Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120.
Biochemistry. 1991 Sep 24;30(38):9187-94
PMID: 1892828